ENTRY       D00512                      Drug
NAME        Phenytoin (JP18/USP/INN);
            Dilantin (TN)
PRODUCT     DILANTIN-125 (Parke-Davis Div of Pfizer)
  GENERIC   DILANTIN INFATABS (Parke-Davis Div of Pfizer)
            PHENYTOIN (ATLANTIC BIOLOGICALS CORP.)
            PHENYTOIN (American Health Packaging)
            PHENYTOIN (American Health Packaging)
            PHENYTOIN (Greenstone LLC)
            PHENYTOIN (Major Pharmaceuticals)
            PHENYTOIN (Major Pharmaceuticals)
            PHENYTOIN (PAI Holdings)
            PHENYTOIN (REMEDYREPACK)
            PHENYTOIN (REMEDYREPACK)
            PHENYTOIN (REMEDYREPACK)
            PHENYTOIN (Taro Pharmaceuticals U.S.A.)
            PHENYTOIN (Taro Pharmaceuticals U.S.A.)
            PHENYTOIN (VistaPharm)
            PHENYTOIN INFATABS (Greenstone LLC)
            PHENYTOIN INFATABS (NCS HealthCare of KY)
            PHENYTOIN INFATABS (NCS HealthCare of KY)
            PHENYTOIN INFATABS (Prasco Laboratories)
FORMULA     C15H12N2O2
EXACT_MASS  252.0899
MOL_WEIGHT  252.268
CLASS       Neuropsychiatric agent
             DG03199  Antiepileptic agent
              DG02031  Hydantoin antiepileptic
            Metabolizing enzyme substrate
             DG01642  CYP2C9 substrate
             DG01639  CYP2C19 substrate
            Metabolizing enzyme inducer
             DG02891  CYP2B6 inducer
             DG02853  CYP3A/CYP3A4 inducer
            Transporter inducer
             DG01893  ABCB1 inducer
REMARK      Same as: C07443
            Therapeutic category: 1132
            ATC code: N03AB02
            Chemical structure group: DG00846
            Product (DG00846): D00512<JP/US> D02103<JP/US>
            Product (mixture): D07583<JP>
EFFICACY    Antiepileptic
COMMENT     Hydantoin derivative
TARGET      SCN1A [HSA:6323] [KO:K04833]
            SCN2A [HSA:6326] [KO:K04834]
            SCN3A [HSA:6328] [KO:K04836]
            SCN4A [HSA:6329] [KO:K04837]
            SCN5A [HSA:6331] [KO:K04838]
            SCN8A [HSA:6334] [KO:K04840]
            SCN9A [HSA:6335] [KO:K04841]
            SCN10A [HSA:6336] [KO:K04842]
            SCN11A [HSA:11280] [KO:K04843]
  PATHWAY   hsa04728(6323)  Dopaminergic synapse
METABOLISM  Enzyme: CYP2C9 [HSA:1559]; CYP2C19 [HSA:1557]
INTERACTION CYP induction: CYP3A [HSA:1576 1577 1551], CYP2B6 [HSA:1555]
            Transporter induction: ABCB1 [HSA:5243]
STR_MAP     map07033  Anticonvulsants
            map07231  Sodium channel blocking drugs
OTHER_MAP   map04976  Bile secretion
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N03 ANTIEPILEPTICS
               N03A ANTIEPILEPTICS
                N03AB Hydantoin derivatives
                 N03AB02 Phenytoin
                  D00512  Phenytoin (JP18/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Anticonvulsants
              Sodium Channel Agents
               Phenytoin
                D00512  Phenytoin (JP18/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               113  Antiepileptics
                1132  Hydantoins
                 D00512  Phenytoin (JP18/USP/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               DG02031  Hydantoin antiepileptic
                DG00846  Phenytoin
                 D00512  Phenytoin
             Metabolizing enzyme substrate
              DG01642  CYP2C9 substrate
               DG00846  Phenytoin
                D00512  Phenytoin
              DG01639  CYP2C19 substrate
               DG00846  Phenytoin
                D00512  Phenytoin
             Metabolizing enzyme inducer
              DG02891  CYP2B6 inducer
               DG00846  Phenytoin
                D00512  Phenytoin
              DG02853  CYP3A/CYP3A4 inducer
               DG00846  Phenytoin
                D00512  Phenytoin
             Transporter inducer
              DG01893  ABCB1 inducer
               DG00846  Phenytoin
                D00512  Phenytoin
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               D00512  Phenytoin
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Sodium channels
                SCN1A
                 D00512  Phenytoin (JP18/USP/INN) &lt;JP/US&gt;
                SCN2A
                 D00512  Phenytoin (JP18/USP/INN) &lt;JP/US&gt;
                SCN3A
                 D00512  Phenytoin (JP18/USP/INN) &lt;JP/US&gt;
                SCN4A
                 D00512  Phenytoin (JP18/USP/INN) &lt;JP/US&gt;
                SCN5A
                 D00512  Phenytoin (JP18/USP/INN) &lt;JP/US&gt;
                SCN8A
                 D00512  Phenytoin (JP18/USP/INN) &lt;JP/US&gt;
                SCN9A
                 D00512  Phenytoin (JP18/USP/INN) &lt;JP/US&gt;
                SCN10A
                 D00512  Phenytoin (JP18/USP/INN) &lt;JP/US&gt;
                SCN11A
                 D00512  Phenytoin (JP18/USP/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00512  Phenytoin
              D00512  Phenytoin tablets
              D00512  Phenytoin powder
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00512
             Drug transporters
              D00512
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D00512
            Prodrugs [br08324.html]
             D00512
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               DG02031  Hydantoin antiepileptic
                DG00846  Phenytoin
             Metabolizing enzyme substrate
              DG01642  CYP2C9 substrate
               DG00846  Phenytoin
              DG01639  CYP2C19 substrate
               DG00846  Phenytoin
             Metabolizing enzyme inducer
              DG02891  CYP2B6 inducer
               DG00846  Phenytoin
              DG02853  CYP3A/CYP3A4 inducer
               DG00846  Phenytoin
             Transporter inducer
              DG01893  ABCB1 inducer
               DG00846  Phenytoin
DBLINKS     CAS: 57-41-0
            PubChem: 7847578
            ChEBI: 8107
            LigandBox: D00512
            NIKKAJI: J2.325F
ATOM        19
            1   C1z C    21.1928  -17.0796
            2   N1x N    21.6897  -15.8145
            3   C2y C    20.5391  -14.9868
            4   N2x N    19.3790  -15.7706
            5   C5x C    19.8336  -17.0686
            6   O1a O    20.5108  -13.5697
            7   O5x O    19.0059  -18.2260
            8   C8y C    22.5928  -17.0796
            9   C8x C    23.2971  -18.2998
            10  C8x C    24.6971  -18.2999
            11  C8x C    25.3972  -17.0875
            12  C8x C    24.6928  -15.8673
            13  C8x C    23.2928  -15.8672
            14  C8y C    21.1928  -18.4796
            15  C8x C    19.9931  -19.1723
            16  C8x C    19.9932  -20.5723
            17  C8x C    21.2057  -21.2722
            18  C8x C    22.4053  -20.5795
            19  C8x C    22.4052  -19.1795
BOND        21
            1     1   2 1
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     1   5 1
            6     3   6 1
            7     5   7 2
            8     1   8 1
            9     8   9 2
            10    9  10 1
            11   10  11 2
            12   11  12 1
            13   12  13 2
            14    8  13 1
            15    1  14 1
            16   14  15 2
            17   15  16 1
            18   16  17 2
            19   17  18 1
            20   18  19 2
            21   14  19 1
///
